FDA Fast Track Designation granted for Phentolamine Ophthalmic Solution 0.75% as treatment of significant chronic night ...

Opus Genetics (IRD) said that the FDA has granted Fast Track designation for Phentolamine Ophthalmic Solution 0.75%, reported ...

Opus Genetics (IRD) announced completion of enrollment in the VEGA-3 Phase 3 clinical trial evaluating Phentolamine Ophthalmic Solution 0.75% ...

Few men use the most effective erection drugs because they must be self-injected into the penis. Few men are willing, but those who do usually like the results.

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month ...

A Pinellas County mom is pushing for more accessible medical food for her 4-year-old son diagnosed with a rare metabolic ...

The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist being investigated to reduce pupil size, and APX3330, a novel ...

Opus Genetics continues to develop its pipeline, including a BEST1 gene therapy expected to enter Phase 1/2 trials in 2025 and treatments for other ophthalmic disorders, such as Phentolamine ...

Ocuphire Pharma meanwhile has a pilocarpine and phentolamine combination that it says could improve vision at a lower dose, avoiding side effects. Phentolamine acts as a pupil dilator. It's a ...

AbbVie has ended speculation about what it will charge for its newly-approved Vuity therapy for presbyopia, a sight condition characterised by difficulty in focusing on near objects. The company ...